ICM
CDMO

ISZO Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

ISZO Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,208,313
Closed -$64.4M – 7
2021
Q4 		$64.4M Sell
2,208,313
-138,648
-6% -$3.97M 33.9% 1
2021
Q3 		$50.6M Hold
2,346,961
– – 22.33% 2
2021
Q2 		$60.2M Hold
2,346,961
– – 21.86% 2
2021
Q1 		$42.8M Sell
2,346,961
-29,750
-1% -$494K 20.16% 3
2020
Q4 		$27.4M Sell
2,376,711
-1,083,177
-31% -$9.9M 28.7% 1
2020
Q3 		$26.4M Sell
3,459,888
-88,144
-2% -$668K 35.45% 2
2020
Q2 		$23.3M Sell
3,548,032
-2,097,669
-37% -$11.7M 40.7% 2
2020
Q1 		$28.9M Buy
5,645,701
+1,425,553
+34% +$8.63M 44.24% 1
2019
Q4 		$32.4M Sell
4,220,148
-314,546
-7% -$1.84M 46.59% 1
2019
Q3 		$24M Sell
4,534,694
-243,429
-5% -$1.51M 31.8% 2
2019
Q2 		$26.8M Buy
4,778,123
+1,532,748
+47% +$6.32M 41.82% 2
2019
Q1 		$13.8M Sell
3,245,375
-244,323
-7% -$997K 22.56% 2
2018
Q4 		$14.3M Buy
+3,489,698
New +$18.2M 15.63% 3

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ISZO Capital Management's CDMO Position: Q1 2022 in Review

ISZO Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 2,208,313 shares — an estimated $64.4M sold.

ISZO Capital Management first reported a position in CDMO in Q4 2018 and held it in 13 quarters. The position peaked at $64.4M in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • ISZO Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • ISZO Capital Management sold 2,208,313 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $64.4M.
  • ISZO Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 13 quarters.
  • ISZO Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $64.4M in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on ISZO Capital Management's 13F filing for Q1 2022, filed 16 May 2022.